Definitive Contract 75N92022C00004
Award Date
11/10/21
Potential Completion Date
11/10/23
Potential Value
$5M
Federal Agency
National Heart Lung and Blood Institute
Awardee
Twist Bioscience Corporation
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The $97,588 contract is for the provision of COVID-19 DNA constructs, which likely support genomics research, disease surveillance, and public health initiatives. This contract does not have a set-aside designation. Twist...
This federal contract award to Twist Bioscience Corporation, a synthetic biology company in South San Francisco, CA, is for the delivery of COVID-19 DNA constructs. The $29,671.85 firm fixed price purchase order was awarded on June 4, 2020 by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH). The contract does not have a set-aside designation. Through this award, as well as previous contracts and grants, Twist...
This federal contract award was issued by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Twist Bioscience Corporation, a for-profit synthetic biology company based in South San Francisco, California. The $125,565.50 firm fixed price purchase order is for the delivery of SARS COV2 RNA control products to support COVID-19 research and diagnostics efforts. The contract does not have a set-aside designation. Twist Bioscience provides various...
This is a firm fixed price purchase order valued at $22,400.00 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation for DNA synthesis services to support gene cloning. The contract has no set-aside designation and the ultimate completion date is December 31, 2024. Twist Bioscience is a synthetic biology company that specializes in manufacturing high-quality synthetic DNA and has...
The Department of Health and Human Services Centers for Disease Control and Prevention (HHS CDC) awarded a firm fixed price purchase order contract to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The $220,065.50 contract is for the provision of SARS COV 2 RNA controls to support COVID-19 research efforts. Twist Bioscience, as a prime contractor, has provided various research products to federal agencies including the NIH, VA, and...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a firm fixed price purchase order valued at $15,117.00 to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The contract is for the delivery of a TWIST Library Preparation Kit 1. This award does not have a set-aside designation. Twist Bioscience is a prime contractor on this purchase order, which has an ultimate completion date of October 14, 2024. The company...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Twist Bioscience Corporation, a for-profit synthetic biology company, to provide TWIST RNA products for the FLUSC2 MULTIPLE program. The $51,160.00 contract does not have a set-aside designation and is scheduled for completion by April 30, 2024. Twist Bioscience, a manufacturer of goods, has previously received numerous federal contracts to supply synthetic...
This firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The contract, valued at $578,224.78, is for the delivery of SC2 POSITIVE CONTROL SYNTHETIC RNA CONTROL MATERIAL. This contract is not associated with a set-aside program. Twist Bioscience has been awarded numerous federal contracts, primarily as a prime contractor, to provide synthetic DNA...
This is a $14,031.25 firm fixed price purchase order awarded by the National Human Genome Research Institute (NHGRI) to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The contract is for Twist Bioscience to provide a custom capture panel to support a new blood-based cancer diagnostic that will detect human herpesvirus 8 (HHV8) in the plasma of HIV patients. The award has an ultimate completion date of October 31, 2024 and was made on August...
This $363,754.94 firm fixed price purchase order from the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) was awarded to Twist Bioscience Corporation, a synthetic biology company, to provide SC2 POSITIVE CONTROL SYNTHETIC RNA CONTROL. The contract does not have a set-aside designation. Twist Bioscience is a for-profit manufacturer based in South San Francisco, California that develops custom oligonucleotides, gene panels, and other synthetic biology...